Management of Coronary Artery Disease in the Setting of Transcatheter Aortic Valve Replacement

Natraj Katta1, J Dawn Abbott2, Ankur Kalra3

  • 1University of Nebraska Medical Center, Omaha, NE, USA.

Heart International
|October 24, 2022
PubMed

Insights

The best way to treat coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR) is unclear. More research is needed to determine if CAD revascularization improves outcomes after TAVR.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Aortic stenosis and coronary artery disease (CAD) often coexist due to shared risk factors and pathophysiology.
  • Optimal management of CAD in patients undergoing transcatheter aortic valve replacement (TAVR) is uncertain due to limited evidence.

Purpose of the Study:

  • To review the current evidence regarding CAD revascularization in patients undergoing TAVR.
  • To highlight the need for further research, specifically randomized controlled trials (RCTs), to guide clinical decision-making.

Main Methods:

  • Review of observational studies and meta-analyses on outcomes of CAD revascularization in TAVR patients.
  • Analysis of factors influencing outcomes, such as residual SYNTAX score (rSS).

Main Results:

  • Existing studies show varied results; no significant difference in post-TAVR outcomes between revascularized and non-revascularized patients.
  • Some evidence suggests lower rSS post-revascularization may correlate with better TAVR outcomes.

Conclusions:

  • The benefit of CAD revascularization in TAVR patients remains inconclusive.
  • Individualized treatment decisions based on heart team consultation are recommended in the absence of definitive RCT data.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
33
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
16
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
41